Clinical evaluation of Norplant in Kumasi, Ghana.
A non-comparative study of the Norplant contraceptive subdermal implant system was conducted in Kumasi, Ghana. A total of 100 acceptors were enrolled in the clinical trial, which began in 1987. There were no pregnancies during the first two years of use. Only nine post-insertion medical problems were reported during the first two years of use. One woman in this study requested removal for menstrual pattern changes through two years of use. As assessed through user-satisfaction questionnaires administered at approximately six months of use, there has been an overall positive user experience with Norplant in this study. Although the sample size in this study is small, our results seem to be consistent with other studies and it appears that Norplant offers an effective, safe and acceptable method of contraception for Ghanaian women.
D000328:Adult; D003271:Contraceptive Agents, Female / Q000627:therapeutic use*; D004343:Drug Implants; D005260:Female; D005500:Follow-Up Studies; D005869:Ghana; D006801:Humans; D016912:Levonorgestrel / Q000627:therapeutic use*; D015993:Life Tables; D017060:Patient Satisfaction; D011795:Surveys and Questionnaires
D003271:Contraceptive Agents, Female; D004343:Drug Implants; D016912:Levonorgestrel